Autologous PSMA-targeted T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous PSMA-targeted T cells, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) [Phase 1]